Drrx stock forecast.

DRRX, Durect - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines. RESEARCH. Shopping Cart. Your cart is ... Durect (DRRX) - Develops pharmaceuticals for chronic pain and central nervous system disorders. GROUP LEADERSHIP Medical-Biomed/Biotech Group. DRRX. is not ranked …Find the latest DURECT Corporation (DRRX) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.Astrotech's stock was trading at $9.99 at the beginning of 2023. Since then, ASTC shares have decreased by 20.9% and is now trading at $7.90. View the best growth stocks for 2023 here.Cascades deeply regrets and is saddened to announce the death of one of its cofounders, Mr. Bernard Lemaire, at the age of 87. Find the latest Cascades Inc. (CAS.TO) stock quote, history, news and other vital information to help you with your stock trading and investing.Get the latest Oncology Pharma Inc (ONPH) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

According to . 2 Wall Street analysts that have issued a 1 year DRRX price target, the average DRRX price target is $34.00, with the highest DRRX stock price forecast at $41.00 and the lowest DRRX stock price forecast at $27.00. DURECT Corporation (Nasdaq: DRRX) ("DURECT"), a biopharmaceutical company focused on developing its epigenetic regulator program for the treatment of acute organ injury and chronic liver diseases ...Find the latest DURECT Corporation (DRRX) stock analysis from Seeking Alpha’s top analysts: exclusive research and insights from bulls and bears. ... Latest Stock Analysis. Follow $0.66 0.01 (+1 ...

If you want to keep up to date on the stock market you have a device in your pocket that makes that possible. Your phone can track everything finance-related and help keep you up to date on the world markets.

DRRX Stock Performance on November 8, 2023: On November 8, 2023, DRRX stock had a volatile day of trading. The stock opened at $0.83 and traded in a range of $0.58 to $0.83 throughout the day. The trading volume was 693,861 shares. DRRX is a pharmaceutical company based in Cupertino, California, with a market capitalization of …See DURECT Corporation (DRRX) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.Get the latest Marker Therapeutics Inc (MRKR) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Nov 16, 2023 · Predictions of DRRX stock price for tomorrow. StockInvest.us is a research service that provides financial data and technical analysis of publicly traded stocks. Overall, the bulls take the lead on this one. Out of 5 total reviews published in the last three months, all 5 analysts rated the stock a Buy. Therefore, the message is clear: AVDL is a Strong Buy ...

Durect Stock Chart and Share Price Forecast, Short-Term "DRRX" Stock Prediction for Next Days and Weeks Walletinvestor.com Durect Corp (DRRX) Forecast Chart, Long-Term Predictions for Next Months and Year: 2023, 2024

Weather forecasts are essential tools for planning our daily activities, especially when it comes to the next 10 days. Understanding a weather 10 day forecast can help us make informed decisions about outdoor events, travel plans, or even w...

May 26, 2020 · DRRX stock forecast Our latest prediction for Durect Corp's stock price was made on the May 26, 2020 when the stock price was at 2.66$. In the short term (2weeks), DRRX's stock price should outperform the market by 4.58%. During that period the price should oscillate between -11.17% and +17.56%. Get the latest AcelRx Pharmaceuticals Inc (ACRX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.DRRX stock recorded 20/30 (67%) green days with 62.91% price volatility over the last 30 days. Based on our DURECT stock forecast, it's now a bad time to buy DRRX stock because it's trading 19.19% above our forecast. Disclaimer: This is not investment advice. The information provided is for general information purposes only.Oct 2, 2023 · Nevertheless, analysts rate DRRX a unanimous strong buy with a $29.80 target, implying 1,097% upside. On the date of publication, ... PayPal Stock Is a No-Gainer, Not a No-Brainer GEVO Stock 12 Months Forecast. $6.47. (528.16% Upside) Based on 3 Wall Street analysts offering 12 month price targets for Gevo in the last 3 months. The average price target is $6.47 with a high forecast of $14.00 and a low forecast of $2.00. The average price target represents a 528.16% change from the last price of $1.03.

Story continues. DURECT Corporation (Nasdaq: DRRX), a biopharmaceutical company focused on developing epigenetic regulator programs for the treatment of acute organ injury and chronic liver ...Nevertheless, the stock market reaction to the news is punishing, with a ~80% drop in the stock price (from $2.58 to $0.53), which was quickly followed by HC Wainwright's downgrade.Mar 24, 2023 · DRRX stock has massive potential and is up 32% so far this year. Analysts have a price target of $34.50, which would be a lofty 650% bump. DRRX stock has a “B” rating in the Portfolio Grader. Find the latest Durect Corporation (DRRX) stock forecast, 12-month price target, predictions and analyst recommendations.Durect (NASDAQ: DRRX) stock is falling hard on Wednesday after the late-stage biopharmaceutical company released results from a Phase 2b clinical trial. This clinical trial covered the efficiency ...

Durect Corp. analyst ratings, historical stock prices, earnings estimates & actuals. DRRX updated stock price target summary.Durect DRRX is set to give its latest quarterly ... New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Zacks Equity Research. Durect (DRRX) came out with a quarterly loss of $0.52 per share versus the Zacks Consensus Estimate of a loss of $0.50. This compares to loss of $0.50 per share a year ago ...The average one-year price target for DRRX / Durect Corp is $6.885. The forecasts range from a low of $5.05 to a high of $8.925. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or ...Get the latest Pieris Pharmaceuticals Inc (PIRS) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.According to our current DRRX stock forecast, the value of DURECT shares will drop by -16.10% and reach $ 0.545352 per share by December 5, 2023. According to our …DURECT Corporation Common Stock (DRRX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.View more. Find the latest DURECT Corporation (DRRX) stock quote, history, news and other vital information to help you with your stock trading and investing.Future criteria checks 2/6. DURECT is forecast to grow earnings and revenue by 16.9% and 47.9% per annum respectively while EPS is expected to grow by 19.9% per annum.DURECT Stock Earnings. The value each DRRX share was expected to gain vs. the value that each DRRX share actually gained. DURECT ( DRRX) reported Q3 2023 earnings per share (EPS) of -$0.11, beating estimates of -$0.41 by 72.98%. In the same quarter last year, DURECT 's earnings per share (EPS) was -$0.11. DURECT is expected to release next ..."DRRX" stock predictions are updated every 5 minutes with latest exchange prices by smart technical market analysis. Q&A about "DRRX" projections. At Walletinvestor.com we …

View DRRX: DURECTinvestment & stock information. Get the latest DRRX: DURECT detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.. ... * Price Target & Stock Forecast ; Full ...

On June 7, 2023, DURECT Corporation announced the successful completion of enrollment for Phase 2b AHFIRM clinical trial. The trial

DRRX: anyone following this stock? It's had quite an amazing run. The OI on the 2.5 dollar jan calls is quite high (much higher than the corresponding puts), and there seems to be two catalysts around the corner with the adcom at Jan 16 as well as the data for Dur-928 due either by the end of this year or early Jan next year. The adcom was ...Being prepared to weather a hurricane — whether that involves fortifying your home or creating an emergency evacuation plan — is an important part of making it through the storm. Hurricanes travel across the ocean via massive, circular gust...Complete Durect Corp. stock information by Barron's. View real-time DRRX stock price and news, along with industry-best analysis. Nov 8, 2023 · Durect Corp (DRRX) $0.66 0.01 (1.54%) 13:00 EST DRRX Stock Quote Delayed 30 Minutes. A share price of Durect Corp [DRRX] is currently trading at $2.92, up 12.31%. An important factor to consider is whether the stock is rising or falling in short-term value. The DRRX shares have gain 13.62% over the last week, with a monthly amount glided 3.55%, and seem to be holding up well over aDurect (NASDAQ: DRRX) is one of my favorite cheap stocks to buy right now. It’s current price looks even more tempting given the company completed a 1-to-10 stock split late last year. Durect is ...Nov 30, 2023 · See the latest Durect Corp stock price (DRRX:XNAS), related news, valuation, dividends and more to help you make your investing decisions. Nov 6, 2023 · The Price and Consensus chart displays the company's stock price along with the consensus estimate. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The ...

Analyst Forecast. According to 4 analysts, the average rating for DRRX stock is "Buy." The 12-month stock price forecast is $36.5, which is an increase of 5,883.61% from the latest price.Find the latest Oncology Pharma Inc. (ONPH) stock quote, history, news and other vital information to help you with your stock trading and investing.Jan 13, 2022 10:00AM EST. A downtrend has been apparent in Durect (DRRX) lately with too much selling pressure. The stock has declined 17.1% over the past four weeks. However, given the fact that ...Instagram:https://instagram. stock quote otop industrial reitshonis wagnersche etf Nov 17, 2023 · Forecst.com predicts future values using technical analysis of a large number of analytical parameters. DRRX stock returns are also predicted based on historical data. According to our research, DRRX stock is a not so good long-term investment. DRRX share price has been in a bull cycle for the past year. mortgage loan 500 credit scorestocktwits tqqq DURECT Stock Earnings. The value each DRRX share was expected to gain vs. the value that each DRRX share actually gained. DURECT ( DRRX) reported Q3 2023 earnings per share (EPS) of -$0.11, beating estimates of -$0.41 by 72.98%. In the same quarter last year, DURECT 's earnings per share (EPS) was -$0.11. DURECT is expected to release next ... best self directed iras Nov 13, 2023 · Nevertheless, the stock market reaction to the news is punishing, with a ~80% drop in the stock price (from $2.58 to $0.53), which was quickly followed by HC Wainwright's downgrade. DRRX Stock Forecast - Is DRRX a buy or sell? Find out now with a free analysis on DURECT. Should I buy or sell DRRX? DRRX Stock Analysis - [Full Report] DRRX Chart by TradingView. Accessories Stocks Animal Stocks Biopharma Stocks Biopharmaceutical Stocks Clinic Stocks Clinical StocksStock Price Forecast. The 8 analysts offering 12-month price forecasts for EyePoint Pharmaceuticals Inc have a median target of 28.00, with a high estimate of 55.00 and a low estimate of 20.00 ...